Bing

SEARCH HISTORY

... investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on MannKind Corporation (NASDAQ:MNKD), Neuralstem, Inc. (NYSEMKT:CUR), Athersys, Inc. (NASDAQ:ATHX). MannKind Corporation …
Market News Call · 1/6/2015
A year ago, they were trading at $2.38. This story was generated by Automated Insights using data from Zacks Investment Research. CUR stock research report from Zacks. Keywords:Neuralstem,Earnings Report Finance Investment & Company Information
Yahoo Finance · 11/7/2014
Brainstorm Cell Therapeutics, Inc. (Nasdaq: BCLI) 47.1% HIGHER; On Dec. 22 it announced it will release the final results from its phase 2a clinical trial of NurOwn in amytrophic lateral sclerosis (ALS) and hold a conference call and webcast to discuss the ...
StreetInsider · 1/2/2015
More from Bing News
At the same time, some Activision stock was bought by an investor group that included Activision CEO Bobby Kotick and co-chairman Brian Kelly. The suit accused them, Vivendi and other individuals of breaching their …
The American Lawyer · 5/21/2015
WMT’s eco­nomic book value is $82 per share today. It’s cur­rent stock price of ~$52 per share implies a per­ma­nent 35% decline in the company’s profits. For most of the first decade of this cen­tury, I con­sid­ered Wal-Mart a good …
Forbes · 6/30/2011
Regenxbio could make an initial public offering of stock later this year, said Chief Executive Officer Ken Mills. The financing, disclosed Wednesday, is the latest sign of a comeback for gene therapy, which aims to cure …
Daily Business Review · 5/20/2015
gene therapy
shareholders may wan to keep their eye on this stock and its positive track record for beating EPS estimates. Neuralstem, Inc. (AMEX: CUR) is focused on developing and commercializing of treatments for central nervous system disease based on …
Investor Place · 8/30/2010
Investors are further cautioned that small-cap and microcap stocks have additional risks that may result in trading at a discount to their peers. Liquidity risk, caused by small trading floats and very low trading volume can lead to large spreads and high ...
Market Watch · 4/27/2015
Nominating Committee Catherine Angell Sohn PharM.D., CLP 35 Relationships 3 Executives Corporate Governance Committee Catherine Angell Sohn PharM.D., CLP 35 Relationships 3 Executives
Bloomberg · 5/19/2015
The stock has now sharply retreated after the company announced a warrant exercise agreement. Neuralstem, Inc. (NYSE: CUR) has a similar situation approaching. The company is expected to provide Phase 2 clinical results for NSI-566 for ALS in the …
Benzinga · 1/13/2015